Click-to-call 810-547-1349

Emerging Industry Professionals and Support Endeavors to Downgrade Cannabis from a Schedule 1 Drug

As reported by NPR in their article “Marijuana could soon be downgraded from a Schedule 1 drug,” the Drug Enforcement Agency (DEA) has begun a review to assess cannabis and if it should still be classified as a Schedule 1 drug.

In a move that is long overdue to many, this review could be game-changing for how cannabis is viewed by the federal government and would be an acknowledgement that the plant has medicinal uses.

“Right now it’s a Schedule 1 drug, the highest level of control, along with LSD, heroin and ecstasy. That means it has a high potential for abuse and no medical uses. On Tuesday, a top health official sent a letter to the Drug Enforcement Administration reportedly recommending that marijuana be downgraded to a Schedule 3 substance, along with ketamine and testosterone,” NPR’s Selena Simmons-Duffin said.

Click here to learn more about the CannaTech industry or click here to read the full article.

Article with all rights reserved, provided by NPR ——

Photo with all rights reserved, provided by Canva ——